反応式
[Br-].[CH3:2][O:3][C:4]([C:6]1[CH:7]=[C:8]([CH:29]=[CH:30][CH:31]=1)[CH2:9][P+](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)=[O:5].CC(C)([O-])C.[K+].[N:38]1([C:44]2[N:49]=[CH:48][C:47]([CH:50]=O)=[CH:46][N:45]=2)[CH2:43][CH2:42][O:41][CH2:40][CH2:39]1>CN(C=O)C>[N:38]1([C:44]2[N:45]=[CH:46][C:47]([CH:50]=[CH:9][C:8]3[CH:7]=[C:6]([CH:31]=[CH:30][CH:29]=3)[C:4]([O:3][CH3:2])=[O:5])=[CH:48][N:49]=2)[CH2:43][CH2:42][O:41][CH2:40][CH2:39]1参加物
実験手順
[3-(Methoxycarbonyl)benzyl](triphenyl)phosphonium bromide (930 mg) was mixed with DMF (6 ml), and potassium tert-butoxide (300 mg) was added thereto at 0° C., followed by stirring for 30 minutes. 2-(Morpholin-4-yl)pyrimidine-5-carboaldehyde (300 mg) was added to the reaction mixture, followed by stirring at 0° C. for 1 hour, and stirring again at room temperature for 1 hour. The reaction mixture was concentrated under reduced pressure, and EtOAc and a saturated aqueous sodium hydrogen carbonate solution were then added thereto. The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane/EtOAc) to obtain methyl 3-{2-[2-(morpholin-4-yl)pyrimidin-5-yl]vinyl}benzoate (377 mg).
後処理
- additionwas added
- customat 0° C.
- stirringby stirring at 0° C. for 1 hour
- stirringstirring again at room temperature for 1 hour
- concentrationThe reaction mixture was concentrated under reduced pressure, and EtOAc
- additiona saturated aqueous sodium hydrogen carbonate solution were then added
- dry with materialThe organic layer was dried over Na2SO4
- concentrationconcentrated under reduced pressure
- customThe obtained residue was purified by silica gel column chromatography (hexane/EtOAc)
出典と根拠
- ORDレコード
- ord-48f5b2f539de47fda0835ba0d15983d5
- 出典データセット
- uspto-grants-2014_05
- 特許番号
- US08716470B2
関連ノート
読み込み中…